PMID- 12600818 OWN - NLM STAT- MEDLINE DCOM- 20030710 LR - 20211203 IS - 1044-1549 (Print) IS - 1044-1549 (Linking) VI - 28 IP - 6 DP - 2003 Jun TI - Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein-1- and nuclear factor-kappaB-mediated gene expression in airway epithelial cells. PG - 762-9 AB - In 16HBE14o- human bronchial epithelial cells, maximal tumor necrosis factor (TNF)-alpha-induced interleukin (IL)-8 expression depends on the activation of two distinct signaling pathways, one constituted in part by activator protein (AP)-1 and the other by nuclear factor (NF)-kappaB. We examined the upstream signaling intermediates responsible for IL-8 and granulocyte-macrophage colony-stimulating factor (GM-CSF) expression in this system, hypothesizing that p21 Ras and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase (MEKK)-1 function as common upstream activators of both the AP-1 and NF-kappaB pathways. TNF-alpha treatment induced both Ras and MEKK1 activation. Dominant-negative forms of Ras (N17Ras) and MEKK1 (MEKK1-KM) each inhibited TNF-alpha-induced transcription from IL-8 and GM-CSF promoters. Ras was required for maximal activation of extracellular signal-regulated kinase (ERK) and Jun amino terminal kinase (JNK) as well as AP-1 and NF-kappaB transcriptional activities, but not for activation of IkappaB kinase (IKK)-beta, an upstream activator of NF-kappaB. MEKK1 was required for maximal activation of ERK, JNK, and IKK, as well as for maximal AP-1 and NF-kappaB transcriptional activities. We conclude that Ras regulates TNF-alpha-induced chemokine expression by activating the AP-1 pathway and enhancing transcriptional function of NF-kappaB, whereas MEKK1 activates both the AP-1 and NF-kappaB pathways. FAU - Zhou, Limei AU - Zhou L AD - Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI 48109-0212, USA. FAU - Tan, Alan AU - Tan A FAU - Iasvovskaia, Svetlana AU - Iasvovskaia S FAU - Li, Jing AU - Li J FAU - Lin, Anning AU - Lin A FAU - Hershenson, Marc B AU - Hershenson MB LA - eng GR - HL56399/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. DEP - 20030131 PL - United States TA - Am J Respir Cell Mol Biol JT - American journal of respiratory cell and molecular biology JID - 8917225 RN - 0 (Interleukin-8) RN - 0 (NF-kappa B) RN - 0 (Transcription Factor AP-1) RN - 0 (Tumor Necrosis Factor-alpha) RN - 83869-56-1 (Granulocyte-Macrophage Colony-Stimulating Factor) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) RN - EC 2.7.11.25 (MAP Kinase Kinase Kinase 1) RN - EC 2.7.11.25 (MAP3K1 protein, human) RN - EC 3.6.5.2 (ras Proteins) SB - IM MH - Bronchi/cytology MH - Cells, Cultured MH - Epithelial Cells/drug effects/*metabolism MH - Gene Expression Regulation/drug effects/*physiology MH - Granulocyte-Macrophage Colony-Stimulating Factor/genetics MH - Humans MH - Interleukin-8/genetics MH - JNK Mitogen-Activated Protein Kinases MH - *MAP Kinase Kinase Kinase 1 MH - Mitogen-Activated Protein Kinases/drug effects/genetics/metabolism MH - Mutation MH - NF-kappa B/genetics/*metabolism MH - Promoter Regions, Genetic MH - Protein Kinases/genetics/metabolism MH - Protein Serine-Threonine Kinases/genetics/*metabolism MH - Signal Transduction/physiology MH - Transcription Factor AP-1/genetics/*metabolism MH - Transcription, Genetic MH - Transcriptional Activation MH - Tumor Necrosis Factor-alpha/metabolism/pharmacology MH - ras Proteins/genetics/*metabolism EDAT- 2003/02/26 04:00 MHDA- 2003/07/11 05:00 CRDT- 2003/02/26 04:00 PHST- 2003/02/26 04:00 [pubmed] PHST- 2003/07/11 05:00 [medline] PHST- 2003/02/26 04:00 [entrez] AID - 2002-0261OC [pii] AID - 10.1165/rcmb.2002-0261OC [doi] PST - ppublish SO - Am J Respir Cell Mol Biol. 2003 Jun;28(6):762-9. doi: 10.1165/rcmb.2002-0261OC. Epub 2003 Jan 31.